Uncategorized

ABBVIE INC. v. APOTEX INC.

In the high-stakes world of pharmaceutical innovation, patent disputes are more than legal battles—they’re pivotal moments that can shape the future of healthcare access and industry dynamics. The recent case of AbbVie Inc. v. Apotex Inc., as detailed …

ABBVIE INC. v. APOTEX INC. Read Post »

General Biotechnology

The Collision of Mandate and Monopoly: An Analysis of Drug Patent Strategies and the Future of the 340B Program

In the high-stakes world of healthcare, few issues are as contentious—and consequential—as the intersection of drug patent strategies and government programs designed to expand access to medicines. The recent analysis titled "The Collision of Mand…

The Collision of Mandate and Monopoly: An Analysis of Drug Patent Strategies and the Future of the 340B Program Read Post »

Biotechblog
Scroll to Top